Navigation Links
Dr. James Douglas Adds Human Growth Hormone (HGH) Therapy to IVF Protocols for Poor Responding Patients
Date:12/18/2012

Plano, Texas (PRWEB) December 18, 2012

As a reproductive endocrinologist, Dr. James Douglas specializes in helping infertile women have children. In some cases, patients do not respond well to fertility treatments, and may mistakenly believe that donor eggs are the only option. To help couples explore alternative therapies before moving to donor eggs, Dr. Douglas has begun utilizing human growth hormone (HGH) to give these patients additional choices.

“I understand the strong desire for a biological child,” explained Dr. Douglas. “We have seen success with HGH therapy in certain cases, and are now recommending it as a course of treatment for some of our poor responding patients.”

Typically, "poor responders" are patients that require increased dosing of gonadotropin therapy, have poor ovarian reserve testing and are over 35. Fertility specialists routinely see this type patients in their offices.

“Often, these women have tried in-vitro fertilization (IVF), and the cycles then failed to result in pregnancy, or were cancelled due to lack of response to medication,” Dr. Douglas said.

The benefits of HGH treatment coupled with ovarian stimulation were first reported 20 years ago. However, this treatment never gained widespread use despite studies touting the benefits.

“More studies are becoming available to support HGH therapy, and the fertility community is responding accordingly,” said Dr. Douglas.

With HGH therapy, patients take subcutaneous injections for six days during the stimulation stage of the IVF cycle. The HGH is thought to help with oocyte maturation, improving egg quality especially in older women.

HGH is also being studied for use in treatment of other medical conditions, such as multiple sclerosis, fibromyalgia, Crohn's disease and ulcerative colitis.

While cautiously optimistic, Dr Douglas sees HGH as a potential second chance for a biological child for some couples struggling with infertility

“We are excited to have another option that may allow our patients to have the babies they so desperately desire,” Dr. Douglas said.

About IVF Plano
For over 20 years, Dr. James Douglas and the team at IVF Plano fertility clinic have served the Dallas area, offering advanced diagnostic tools, the latest treatments for infertility and exceptional pregnancy rates. Dr. Douglas has helped thousands of patients in the Plano TX area achieve their goals of starting or expanding their families. For more information about the clinic, please visit http://www.ivfplano.com

Read the full story at http://www.prweb.com/releases/ivfplano/12/prweb10228871.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. James bond: A graphene/nanotube hybrid
2. Laureate Biopharma Names James D. Utterback to Board of Directors
3. Herbal Microscopy Book Receives American Botanical Councils James A. Duke Book Award
4. InspireMD Appoints Dr. James Barry to Its Board of Directors
5. MAP Pharmaceuticals Appoints W. James OShea to Board of Directors
6. Aviir, Inc.s CEO Dr. Douglas Harrington Delivered The Facts Surrounding Heart Disease At The Los Angeles Ultimate Womens Expo
7. BioHealth Innovation, Inc. Appoints Qiagens Douglas Liu to Board of Directors
8. Major Diabetes Peer-Review Journal Publishes Postive Results Of Ultradian Diagnostics Human Pilot Study
9. Remixed brain waves reveal soundtrack of the human brain
10. Harvards Wyss Institute models a human disease in an organ-on-a-chip
11. Antibiotic contamination a threat to humans and the environment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... ROTTERDAM, the Netherlands and LAGUNA HILLS, ... that The Institute of Cancer Research, London ... will use MMprofiler™ with SKY92, SkylineDx,s prognostic tool to risk-stratify ... high-risk trial known as MUK nine . The University ... this trial, which is partly funded by Myeloma UK, and ...
(Date:10/11/2017)... Bay, Florida (PRWEB) , ... October 11, 2017 ... ... and Drug Administration (FDA) has granted orphan drug designation to SBT-100, its novel ... (sdAb) for the treatment of osteosarcoma. SBT-100 is able to cross the cell ...
(Date:10/10/2017)... ... 10, 2017 , ... For the second time in three ... Mentoring Award. Representatives of the FirstHand program travelled to Washington, D.C. Tuesday, October ... US2020’s mission is to change the trajectory of STEM education in America by ...
(Date:10/10/2017)... CRUZ, Calif. , Oct. 10, 2017 ... grant from the NIH to develop RealSeq®-SC (Single Cell), ... kit for profiling small RNAs (including microRNAs) from single ... Analysis Program highlights the need to accelerate development of ... "New techniques for measuring ...
Breaking Biology Technology:
(Date:6/30/2017)... 30, 2017 Today, American Trucking Associations ... of face and eye tracking software, became the ... program. "Artificial intelligence and advanced ... monitor a driver,s attentiveness levels while on the ... to detect fatigue and prevent potential accidents, which ...
(Date:6/14/2017)... IBM ) is introducing several innovative partner startups at VivaTech ... startups and global businesses, taking place in Paris ... will showcase the solutions they have built with IBM Watson ... France is one of the most dynamic ... in the number of startups created between 2012 and 2015*, ...
(Date:5/16/2017)... 16, 2017  Veratad Technologies, LLC ( www.veratad.com ), ... and identity verification solutions, announced today they will participate ... May 15 thru May 17, 2017, in ... Trade Center. Identity impacts the lives ... today,s quickly evolving digital world, defining identity is critical ...
Breaking Biology News(10 mins):